Trump and RFK Jr. Announce Federal Autism Studies

September 23, 2025 • by DailyClout

In a historic move, U.S. public health agencies will begin extensive new studies into all possible causes of autism, including vaccines, U.S. Health Secretary Robert F. Kennedy Jr., President Donald Trump, and other officials announced today during a White House event.

The initiative will mark the first time federal agencies directly address the autism epidemic by openly studying environmental, pharmaceutical, and genetic causes together.

FDA Issues Tylenol Warnings for Pregnant Women

As part of the announcement, the U.S. Food and Drug Administration (FDA) confirmed it will immediately require warning labels on Tylenol and other acetaminophen-based products, citing studies linking prenatal use to autism risks in children. Physicians and the public will also be formally advised of potential dangers.

Shares of Tylenol’s manufacturer, Kenvue Inc., fell over 7% on the news, as concerns mount over acetaminophen’s safety profile.

New Autism Treatment Approved

The FDA will also move to approve leucovorin, a drug typically used in cancer therapy, as a treatment for certain autism-related symptoms in children with folate deficiency. Clinical studies have shown promising results in improving behavior and communication.

Kennedy and Trump Highlight Vaccines in Autism Debate

Kennedy stressed that vaccine safety will be a key focus of the new studies:

“Some 70% of mothers who have children with autism believe their child was injured by a vaccine. We will perform the studies that should have been performed 25 years ago. Whatever the answer is, we will tell you what we find.”

Trump echoed this concern, citing a 400% rise in autism diagnoses since 2000 and questioning the impact of the childhood vaccination schedule:

“They pump so much stuff into those beautiful little babies. It’s a disgrace. … I think I can say that there are certain groups of people that don’t take vaccines or pills that have no autism.”

Rising Autism Rates Confirmed by CDC

The Centers for Disease Control and Prevention (CDC) recently reported that 1 in 31 children had an autism spectrum disorder (ASD) diagnosis in 2022 — a sharp rise from 1 in 36 in 2020 and 1 in 1,000 in the 1990s.

Advocates Welcome Shift in Federal Autism Research

Mary Holland, CEO of Children’s Health Defense, praised the announcement as “historic”:

“This is the first time public health officials have introduced a treatment program while promising to identify all potential causes — including vaccines — to help prevent future cases of autism.”

John Gilmore, of the Autism Action Network, said the decision “shattered two taboos” by acknowledging environmental causes and possible medical contributions like Tylenol use during pregnancy.

NIH Launches Autism Data Science Initiative

The National Institutes of Health (NIH) also confirmed the launch of its Autism Data Science Initiative, a multi-team research effort to analyze environmental and medical factors driving the surge in diagnoses.

Kennedy promised transparency in the research process:

“We will be uncompromising and relentless in our search for answers. The safety of mothers, children, and families depends on it.”

Why This Matters

Today’s announcements represent a significant turning point in U.S. autism research. For the first time, federal agencies will examine vaccines, medications, and environmental triggers side by side, while also offering potential new treatments for millions of children already affected.

With autism rates continuing to rise, the studies could reshape public health policy, pharmaceutical regulation, and parental decision-making for years to come.

DailyClout.IO will continue to follow this story. Follow Naomi Wolf on Substack for exclusive videos and essays.

Source and further reading:

Spread the Word